Skip to main content
Industry News
Selective inhibitor may curb treatment resistance in cancer

New Zealand researchers have created a selective inhibitor through the chemical modification of DNA molecules that can inhibit APOBEC3B, an enzyme in cancer cells that causes treatment resistance in tumors. The findings in the journal Organic & Biomolecular Chemistry suggest that the selective inhibitor could help lead to the development of a novel class of cancer treatments.

Full Story: